-
2
-
-
34247606468
-
Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis
-
Alexia C, Bras M, Fallot G, Vadrot N, Daniel F, Lasfer M, Tamouza H, Groyer A. 2006. Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis. Ann NY Acad Sci 1090: 1-17.
-
(2006)
Ann NY Acad Sci
, vol.1090
, pp. 1-17
-
-
Alexia, C.1
Bras, M.2
Fallot, G.3
Vadrot, N.4
Daniel, F.5
Lasfer, M.6
Tamouza, H.7
Groyer, A.8
-
3
-
-
51349164790
-
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
-
Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP. 2008. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118: 3065-3074.
-
(2008)
J Clin Invest
, vol.118
, pp. 3065-3074
-
-
Carracedo, A.1
Ma, L.2
Teruya-Feldstein, J.3
Rojo, F.4
Salmena, L.5
Alimonti, A.6
Egia, A.7
Sasaki, A.T.8
Thomas, G.9
Kozma, S.C.10
Papa, A.11
Nardella, C.12
Cantley, L.C.13
Baselga, J.14
Pandolfi, P.P.15
-
4
-
-
15544382574
-
Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study
-
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. 2005. Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study. Gut 54: 533-539.
-
(2005)
Gut
, vol.54
, pp. 533-539
-
-
Davila, J.A.1
Morgan, R.O.2
Shaib, Y.3
McGlynn, K.A.4
El-Serag, H.B.5
-
5
-
-
70350545722
-
Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1
-
Dibble CC, Asara JM, Manning BD. 2009. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol Cell Biol 29: 5657-5670.
-
(2009)
Mol Cell Biol
, vol.29
, pp. 5657-5670
-
-
Dibble, C.C.1
Asara, J.M.2
Manning, B.D.3
-
6
-
-
59249086448
-
Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin
-
Donadon V, Balbi M, Casarin P, Vario A, Alberti A. 2008. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin. World J Gastroenterol 14: 5695-5700.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 5695-5700
-
-
Donadon, V.1
Balbi, M.2
Casarin, P.3
Vario, A.4
Alberti, A.5
-
7
-
-
71849091933
-
CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo
-
Dormond O, Contreras AG, Meijer E, Datta D, Flynn E, Pal S, Briscoe DM. 2008. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. J Immunol 181: 8088-8095.
-
(2008)
J Immunol
, vol.181
, pp. 8088-8095
-
-
Dormond, O.1
Contreras, A.G.2
Meijer, E.3
Datta, D.4
Flynn, E.5
Pal, S.6
Briscoe, D.M.7
-
9
-
-
67651148536
-
S6K1 deficiency protects against apoptosis in hepatocytes
-
Gonzalez-Rodriguez A, Alba J, Zimmerman V, Kozma SC, Valverde AM. 2009. S6K1 deficiency protects against apoptosis in hepatocytes. Hepatology 50: 216-229.
-
(2009)
Hepatology
, vol.50
, pp. 216-229
-
-
Gonzalez-Rodriguez, A.1
Alba, J.2
Zimmerman, V.3
Kozma, S.C.4
Valverde, A.M.5
-
10
-
-
34347220473
-
Defining the role of mTOR in cancer
-
Guertin DA, Sabatini DM. 2007. Defining the role of mTOR in cancer. Cancer Cell 12: 9-22.
-
(2007)
Cancer Cell
, vol.12
, pp. 9-22
-
-
Guertin, D.A.1
Sabatini, D.M.2
-
11
-
-
58649114084
-
mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice
-
Guertin DA, Stevens DM, Saitoh M, Kinkel S, Crosby K, Sheen JH, Mullholland DJ, Magnuson MA, Wu H, Sabatini DM. 2009. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15: 148-159.
-
(2009)
Cancer Cell
, vol.15
, pp. 148-159
-
-
Guertin, D.A.1
Stevens, D.M.2
Saitoh, M.3
Kinkel, S.4
Crosby, K.5
Sheen, J.H.6
Mullholland, D.J.7
Magnuson, M.A.8
Wu, H.9
Sabatini, D.M.10
-
12
-
-
57649096459
-
mTOR-What does it do?
-
Hall MN. 2008. mTOR-What does it do? Transplant Proc 40: S5-S8.
-
(2008)
Transplant Proc
, vol.40
-
-
Hall, M.N.1
-
13
-
-
54049100759
-
TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells
-
Hietakangas V, Cohen SM. 2008. TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells. BMC Cancer 8: 282.
-
(2008)
BMC Cancer
, vol.8
, pp. 282
-
-
Hietakangas, V.1
Cohen, S.M.2
-
14
-
-
0037470863
-
Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system
-
Ijichi C, Matsumura T, Tsuji T, Eto Y. 2003. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 303: 59-64.
-
(2003)
Biochem Biophys Res Commun
, vol.303
, pp. 59-64
-
-
Ijichi, C.1
Matsumura, T.2
Tsuji, T.3
Eto, Y.4
-
15
-
-
33749031867
-
Diabetes mellitus and the risk of cancer: Results from a large-scale population-based cohort study in Japan
-
Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. 2006. Diabetes mellitus and the risk of cancer: Results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871-1877.
-
(2006)
Arch Intern Med
, vol.166
, pp. 1871-1877
-
-
Inoue, M.1
Iwasaki, M.2
Otani, T.3
Sasazuki, S.4
Noda, M.5
Tsugane, S.6
-
16
-
-
75649149159
-
Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice
-
Iwasa J, Shimizu M, Shiraki M, Shirakami Y, Sakai H, Terakura Y, Takai K, Tsurumi H, Tanaka T, Moriwaki H. 2010. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Sci 101: 460-467.
-
(2010)
Cancer Sci
, vol.101
, pp. 460-467
-
-
Iwasa, J.1
Shimizu, M.2
Shiraki, M.3
Shirakami, Y.4
Sakai, H.5
Terakura, Y.6
Takai, K.7
Tsurumi, H.8
Tanaka, T.9
Moriwaki, H.10
-
17
-
-
35148845135
-
Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: Report of two cases
-
Kawaguchi T, Taniguchi E, Itou M, Sumie S, Oriishi T, Matsuoka H, Nagao Y, Sata M. 2007. Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: Report of two cases. Liver Int 27: 1287-1292.
-
(2007)
Liver Int
, vol.27
, pp. 1287-1292
-
-
Kawaguchi, T.1
Taniguchi, E.2
Itou, M.3
Sumie, S.4
Oriishi, T.5
Matsuoka, H.6
Nagao, Y.7
Sata, M.8
-
18
-
-
52049096635
-
Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease
-
Kawaguchi T, Nagao Y, Matsuoka H, Ide T, Sata M. 2008. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med 22: 105-112.
-
(2008)
Int J Mol Med
, vol.22
, pp. 105-112
-
-
Kawaguchi, T.1
Nagao, Y.2
Matsuoka, H.3
Ide, T.4
Sata, M.5
-
19
-
-
21444454939
-
Blocking of PI3K/Akt pathway enhances apoptosis induced by SN-38, an active form of CPT-11, in human hepatoma cells
-
Koizumi N, Hatano E, Nitta T, Tada M, Harada N, Taura K, Ikai I, Shimahara Y. 2005. Blocking of PI3K/Akt pathway enhances apoptosis induced by SN-38, an active form of CPT-11, in human hepatoma cells. Int J Oncol 26: 1301-1306.
-
(2005)
Int J Oncol
, vol.26
, pp. 1301-1306
-
-
Koizumi, N.1
Hatano, E.2
Nitta, T.3
Tada, M.4
Harada, N.5
Taura, K.6
Ikai, I.7
Shimahara, Y.8
-
20
-
-
33745556520
-
Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection
-
Lai MS, Hsieh MS, Chiu YH, Chen TH. 2006. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 43: 1295-1302.
-
(2006)
Hepatology
, vol.43
, pp. 1295-1302
-
-
Lai, M.S.1
Hsieh, M.S.2
Chiu, Y.H.3
Chen, T.H.4
-
21
-
-
70350418625
-
mTOR signaling at a glance
-
Laplante M, Sabatini DM. 2009. mTOR signaling at a glance. J Cell Sci 122: 3589-3594.
-
(2009)
J Cell Sci
, vol.122
, pp. 3589-3594
-
-
Laplante, M.1
Sabatini, D.M.2
-
22
-
-
20344404975
-
Branched-chain amino acid supplementation in patients with liver diseases
-
Marchesini G, Marzocchi R, Noia M, Bianchi G. 2005. Branched-chain amino acid supplementation in patients with liver diseases. J Nutr 135: 1596S-1601S.
-
(2005)
J Nutr
, vol.135
-
-
Marchesini, G.1
Marzocchi, R.2
Noia, M.3
Bianchi, G.4
-
23
-
-
26844555799
-
Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver
-
Matsumura T, Morinaga Y, Fujitani S, Takehana K, Nishitani S, Sonaka I. 2005. Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver. Hepatol Res 33: 27-32.
-
(2005)
Hepatol Res
, vol.33
, pp. 27-32
-
-
Matsumura, T.1
Morinaga, Y.2
Fujitani, S.3
Takehana, K.4
Nishitani, S.5
Sonaka, I.6
-
24
-
-
67149131861
-
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model
-
Mi R, Ma J, Zhang D, Li L, Zhang H. 2009. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model. J Genet Genomics 36: 355-361.
-
(2009)
J Genet Genomics
, vol.36
, pp. 355-361
-
-
Mi, R.1
Ma, J.2
Zhang, D.3
Li, L.4
Zhang, H.5
-
25
-
-
22144472524
-
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis
-
Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H. 2005. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3: 705-713.
-
(2005)
Clin Gastroenterol Hepatol
, vol.3
, pp. 705-713
-
-
Muto, Y.1
Sato, S.2
Watanabe, A.3
Moriwaki, H.4
Suzuki, K.5
Kato, A.6
Kato, M.7
Nakamura, T.8
Higuchi, K.9
Nishiguchi, S.10
Kumada, H.11
-
26
-
-
33745727871
-
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
-
Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H, Ohashi Y. 2006. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 35: 204-214.
-
(2006)
Hepatol Res
, vol.35
, pp. 204-214
-
-
Muto, Y.1
Sato, S.2
Watanabe, A.3
Moriwaki, H.4
Suzuki, K.5
Kato, A.6
Kato, M.7
Nakamura, T.8
Higuchi, K.9
Nishiguchi, S.10
Kumada, H.11
Ohashi, Y.12
-
27
-
-
0036288123
-
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
-
Nair S, Mason A, Eason J, Loss G, Perrillo RP. 2002. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36: 150-155.
-
(2002)
Hepatology
, vol.36
, pp. 150-155
-
-
Nair, S.1
Mason, A.2
Eason, J.3
Loss, G.4
Perrillo, R.P.5
-
29
-
-
32944457518
-
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
-
O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, Baselga J, Rosen N. 2006. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66: 1500-1508.
-
(2006)
Cancer Res
, vol.66
, pp. 1500-1508
-
-
O'Reilly, K.E.1
Rojo, F.2
She, Q.B.3
Solit, D.4
Mills, G.B.5
Smith, D.6
Lane, H.7
Hofmann, F.8
Hicklin, D.J.9
Ludwig, D.L.10
Baselga, J.11
Rosen, N.12
-
30
-
-
3342895823
-
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
-
Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. 2004. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296-1302.
-
(2004)
Curr Biol
, vol.14
, pp. 1296-1302
-
-
Sarbassov, D.D.1
Ali, S.M.2
Kim, D.H.3
Guertin, D.A.4
Latek, R.R.5
Erdjument-Bromage, H.6
Tempst, P.7
Sabatini, D.M.8
-
32
-
-
13844312400
-
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
-
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005b. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
-
(2005)
Science
, vol.307
, pp. 1098-1101
-
-
Sarbassov, D.D.1
Guertin, D.A.2
Ali, S.M.3
Sabatini, D.M.4
-
33
-
-
33646023695
-
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
-
Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168.
-
(2006)
Mol Cell
, vol.22
, pp. 159-168
-
-
Sarbassov, D.D.1
Ali, S.M.2
Sengupta, S.3
Sheen, J.H.4
Hsu, P.P.5
Bagley, A.F.6
Markhard, A.L.7
Sabatini, D.M.8
-
34
-
-
0018849684
-
Tumor host relations. V. Nitrogen metabolism in Yoshida sarcoma-bearing rats. Reduction of growth rate and increase of survival time by administration of physiological doses of branched-chain amino acids
-
Schaur RJ, Semmelrock HJ, Schreibmayer W, Tillian HM, Schauenstein E. 1980. Tumor host relations. V. Nitrogen metabolism in Yoshida sarcoma-bearing rats. Reduction of growth rate and increase of survival time by administration of physiological doses of branched-chain amino acids. J Cancer Res Clin Oncol 97: 285-293.
-
(1980)
J Cancer Res Clin Oncol
, vol.97
, pp. 285-293
-
-
Schaur, R.J.1
Semmelrock, H.J.2
Schreibmayer, W.3
Tillian, H.M.4
Schauenstein, E.5
-
35
-
-
33745325163
-
Diabetes, insulin, and risk of cancer
-
Schiel R, Beltschikow W, Steiner T, Stein G. 2006. Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol 28: 169-175.
-
(2006)
Methods Find Exp Clin Pharmacol
, vol.28
, pp. 169-175
-
-
Schiel, R.1
Beltschikow, W.2
Steiner, T.3
Stein, G.4
-
36
-
-
51849111524
-
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
-
Serra V, Markman B, Scaltriti M, Eichhorn PJ, Valero V, Guzman M, Botero ML, Llonch E, Atzori F, Di Cosimo S, Maira M, Garcia-Echeverria C, Parra JL, Arribas J, Baselga J. 2008. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations. Cancer Res 68: 8022-8030.
-
(2008)
Cancer Res
, vol.68
, pp. 8022-8030
-
-
Serra, V.1
Markman, B.2
Scaltriti, M.3
Eichhorn, P.J.4
Valero, V.5
Guzman, M.6
Botero, M.L.7
Llonch, E.8
Atzori, F.9
Di Cosimo, S.10
Maira, M.11
Garcia-Echeverria, C.12
Parra, J.L.13
Arribas, J.14
Baselga, J.15
-
37
-
-
65649099102
-
Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice
-
Shimizu M, Shirakami Y, Iwasa J, Shiraki M, Yasuda Y, Hata K, Hirose Y, Tsurumi H, Tanaka T, Moriwaki H. 2009. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Clin Cancer Res 15: 3068-3075.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3068-3075
-
-
Shimizu, M.1
Shirakami, Y.2
Iwasa, J.3
Shiraki, M.4
Yasuda, Y.5
Hata, K.6
Hirose, Y.7
Tsurumi, H.8
Tanaka, T.9
Moriwaki, H.10
-
38
-
-
28844437366
-
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy
-
Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, Wacheck V. 2006. Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy. J Hepatol 44: 151-157.
-
(2006)
J Hepatol
, vol.44
, pp. 151-157
-
-
Sieghart, W.1
Losert, D.2
Strommer, S.3
Cejka, D.4
Schmid, K.5
Rasoul-Rockenschaub, S.6
Bodingbauer, M.7
Crevenna, R.8
Monia, B.P.9
Peck-Radosavljevic, M.10
Wacheck, V.11
-
39
-
-
33947501692
-
Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation
-
Sieghart W, Fuereder T, Schmid K, Cejka D, Werzowa J, Wrba F, Wang X, Gruber D, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Wacheck V. 2007. Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation. Transplantation 83: 425-432.
-
(2007)
Transplantation
, vol.83
, pp. 425-432
-
-
Sieghart, W.1
Fuereder, T.2
Schmid, K.3
Cejka, D.4
Werzowa, J.5
Wrba, F.6
Wang, X.7
Gruber, D.8
Rasoul-Rockenschaub, S.9
Peck-Radosavljevic, M.10
Wacheck, V.11
-
40
-
-
23844438209
-
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
-
Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, Fu H, Khuri FR. 2005. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res 65: 7052-7058.
-
(2005)
Cancer Res
, vol.65
, pp. 7052-7058
-
-
Sun, S.Y.1
Rosenberg, L.M.2
Wang, X.3
Zhou, Z.4
Yue, P.5
Fu, H.6
Khuri, F.R.7
-
41
-
-
57349087153
-
Pivotal role of mTOR signaling in hepatocellular carcinoma
-
Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM. 2008. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 135: 1972-1983.
-
(2008)
Gastroenterology
, vol.135
, pp. 1972-1983
-
-
Villanueva, A.1
Chiang, D.Y.2
Newell, P.3
Peix, J.4
Thung, S.5
Alsinet, C.6
Tovar, V.7
Roayaie, S.8
Minguez, B.9
Sole, M.10
Battiston, C.11
Van Laarhoven, S.12
Fiel, M.I.13
Di Feo, A.14
Hoshida, Y.15
Yea, S.16
Toffanin, S.17
Ramos, A.18
Martignetti, J.A.19
Mazzaferro, V.20
Bruix, J.21
Waxman, S.22
Schwartz, M.23
Meyerson, M.24
Friedman, S.L.25
Llovet, J.M.26
more..
-
42
-
-
67349195436
-
Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats
-
Yoshiji H, Noguchi R, Kitade M, Kaji K, Ikenaka Y, Namisaki T, Yoshii J, Yanase K, Yamazaki M, Tsujimoto T, Akahane T, Kawaratani H, Uemura M, Fukui H. 2009. Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats. J Gastroenterol 44: 483-491.
-
(2009)
J Gastroenterol
, vol.44
, pp. 483-491
-
-
Yoshiji, H.1
Noguchi, R.2
Kitade, M.3
Kaji, K.4
Ikenaka, Y.5
Namisaki, T.6
Yoshii, J.7
Yanase, K.8
Yamazaki, M.9
Tsujimoto, T.10
Akahane, T.11
Kawaratani, H.12
Uemura, M.13
Fukui, H.14
-
43
-
-
79952293503
-
Activation of mTORC2 by association with the ribosome
-
Zinzalla V, Stracka D, Oppliger W, Hall MN. 2011. Activation of mTORC2 by association with the ribosome. Cell 144: 757-768.
-
(2011)
Cell
, vol.144
, pp. 757-768
-
-
Zinzalla, V.1
Stracka, D.2
Oppliger, W.3
Hall, M.N.4
|